Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market
Holding RCUS?
Track your performance easily

Arcus Biosciences (RCUS) Financial Statements

446 Followers

Arcus Biosciences Financial Overview

Arcus Biosciences's market cap is currently ―. The company's EPS TTM is $-3.099; its P/E ratio is -5.27; Arcus Biosciences is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-1.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 39.00M$ 145.00M$ 31.00M$ 32.00M$ 29.00M
Gross Profit$ 39.00M$ 145.00M$ 31.00M$ 32.00M$ 29.00M
EBIT$ -93.00M$ -3.00M$ -80.00M$ -69.00M$ -74.00M
EBITDA$ -83.00M$ -5.00M$ -77.00M$ -71.00M$ -74.00M
Net Income Common Stockholders$ -106.00M$ -4.00M$ -81.00M$ -71.00M$ -75.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 969.00M$ 995.00M$ 759.00M$ 799.00M$ 930.00M
Total Assets$ 1.19B$ 1.29B$ 1.09B$ 1.19B$ 1.22B
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -969.00M$ -995.00M$ -759.00M$ -799.00M$ -930.00M
Total Liabilities$ 551.00M$ 586.00M$ 633.00M$ 671.00M$ 654.00M
Stockholders Equity$ 635.00M$ 707.00M$ 462.00M$ 520.00M$ 566.00M
Cash Flow-
Free Cash Flow$ -94.00M$ -6.00M$ -94.00M$ -73.00M$ -62.00M
Operating Cash Flow$ -94.00M$ -2.00M$ -88.00M$ -63.00M$ -57.00M
Investing Cash Flow$ 63.00M$ -169.00M$ 28.00M$ 11.00M$ 26.00M
Financing Cash Flow$ 2.00M$ 229.00M$ 3.00M$ 6.00M$ 23.00M
Currency in USD

Arcus Biosciences Earnings and Revenue History

Arcus Biosciences Debt to Assets

Arcus Biosciences Cash Flow

Arcus Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis